Search
for
Sort by
Research 31–60 of 1000+
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- A review of Janus kinase inhibitor use in scarring alopecia
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- New drugs under investigation for the treatment of alopecias
- Treatment of severe alopecia areata with baricitinib
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Alopecia Areata
- Alopecia Areata
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib